The vitamin E analog, alpha-tocopheryloxyacetic acid enhances the anti-tumor activity of trastuzumab against HER2/neu-expressing breast cancer

BACKGROUND: HER2/neu is an oncogene that facilitates neoplastic transformation due to its ability to transduce growth signals in a ligand-independent manner, is over-expressed in 20-30% of human breast cancers correlating with aggressive disease and has been successfully targeted with trastuzumab (H...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Hahn, Tobias, Bradley-Dunlop, Deborah J, Hurley, Laurence H, Von-Hoff, Daniel, Gately, Stephen, Mary, Disis L, Lu, Hailing, Penichet, Manuel L, Besselsen, David G, Cole, Brook B, Meeuwsen, Tanisha, Walker, Edwin, Akporiaye, Emmanuel T
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2011
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3217981/
https://ncbi.nlm.nih.gov/pubmed/22044845
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-11-471
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars